Adherence in Pediatric Multiple Sclerosis

Summary

Disease modifying therapies (DMT) are widely used for children and adolescents with MS. Nonetheless, many pediatric patients continue to relapse and therefore require changes in therapy. We designed this research study to learn more about medication use in children and adolescents with MS. We are also interested in learning what a behavioral feedback intervention can tell us about adherence to medicine. Finally, we hope this research project will inform the way we provide clinical care for children and adolescents with MS.

Conditions

• Multiple Sclerosis

Interventions

BEHAVIORAL

Motivational Interview

OTHER

Video Attention Control

Sponsors & Collaborators

• National Multiple Sclerosis Society

  collaborator OTHER

• Loma Linda University

  collaborator OTHER

• University of Pittsburgh

  collaborator OTHER

• Children's Hospital of Philadelphia

  collaborator OTHER

• Boston Children's Hospital

  collaborator OTHER

• Baylor College of Medicine

  collaborator OTHER

• University of Alabama at Birmingham

  collaborator OTHER

• Mayo Clinic

  collaborator OTHER

• University of Colorado, Denver

  collaborator OTHER

• University of California, San Francisco

  collaborator OTHER

• Washington University School of Medicine

  collaborator OTHER

• Alberta Children's Hospital

  collaborator OTHER

• The Cleveland Clinic

  collaborator OTHER

• DeltaQuest Foundation

  collaborator UNKNOWN

• The Hospital for Sick Children

  lead OTHER

Principal Investigators

• E. Ann Yeh, MD · University of Toronto, The Hospital for Sick Children

Study Design

Allocation

RANDOMIZED

Purpose

OTHER

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

10 Years

Max Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2013-01-31

Primary Completion

2016-07-31

Completion

2016-09-30

Countries

• United States
• Canada

Study Locations